Journal article

Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design

Amanda TS Albanaz, Carlos HM Rodrigues, Douglas EV Pires, David B Ascher

Expert Opinion on Drug Discovery | TAYLOR & FRANCIS LTD | Published : 2017

Grants

Awarded by Jack Brockhoff Foundation (JBF)


Awarded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)


Awarded by initiative of the Victorian Government, Australia


Awarded by C. J. Martin Research Fellowship from the National Health and Medical Research Council of Australia


Funding Acknowledgements

This work was funded by the Jack Brockhoff Foundation (JBF 4186, 2016) and a Newton Fund RCUK-CONFAP Grant awarded by The Medical Research Council (MRC) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (MR/M026302/1). This research was supported by the Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government, Australia, on its Facility hosted at the University of Melbourne (UOM0017). DEV Pires receives support from the Rene Rachou Research Center (CPqRR/FIOCRUZ Minas), Brazil. DB Ascher is supported by a C. J. Martin Research Fellowship from the National Health and Medical Research Council of Australia (APP1072476), and the Department of Biochemistry, University of Melbourne.